The FDA performed only a third of its usual number of inspections last year because of the Covid-19 pandemic, but the number of GMP inspections it carried out in the US was already declining.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,